B. Metzler seel. Sohn & Co. AG increased its position in Synopsys, Inc. (NASDAQ:SNPS - Free Report) by 6.3% in the 4th quarter, according to its most recent filing with the SEC. The fund owned 97,680 shares of the semiconductor company's stock after purchasing an additional 5,773 shares during the period. B. Metzler seel. Sohn & Co. AG owned 0.06% of Synopsys worth $47,419,000 at the end of the most recent quarter.
Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Kieckhefer Group LLC acquired a new stake in Synopsys during the 4th quarter worth approximately $27,000. Whipplewood Advisors LLC acquired a new stake in shares of Synopsys during the fourth quarter worth $33,000. Sierra Ocean LLC purchased a new position in Synopsys in the 4th quarter valued at $39,000. Hazlett Burt & Watson Inc. increased its stake in Synopsys by 28.6% in the 4th quarter. Hazlett Burt & Watson Inc. now owns 90 shares of the semiconductor company's stock valued at $44,000 after buying an additional 20 shares during the period. Finally, Newbridge Financial Services Group Inc. purchased a new position in Synopsys during the 4th quarter worth $51,000. Hedge funds and other institutional investors own 85.47% of the company's stock.
Analysts Set New Price Targets
SNPS has been the topic of a number of recent analyst reports. Redburn Atlantic assumed coverage on shares of Synopsys in a research note on Monday, January 13th. They set a "buy" rating and a $600.00 price target on the stock. Wells Fargo & Company reduced their price target on Synopsys from $540.00 to $520.00 and set an "equal weight" rating for the company in a report on Thursday, February 27th. Morgan Stanley dropped their price objective on Synopsys from $625.00 to $590.00 and set an "overweight" rating on the stock in a report on Monday, February 24th. Rosenblatt Securities reissued a "buy" rating and issued a $660.00 target price on shares of Synopsys in a report on Tuesday, February 25th. Finally, Needham & Company LLC reaffirmed a "buy" rating and set a $650.00 price target on shares of Synopsys in a research note on Thursday, February 27th. One research analyst has rated the stock with a hold rating and eleven have given a buy rating to the company's stock. According to data from MarketBeat, the stock currently has an average rating of "Moderate Buy" and an average target price of $638.58.
Read Our Latest Analysis on SNPS
Insider Transactions at Synopsys
In other news, insider Geus Aart De sold 15,705 shares of the business's stock in a transaction that occurred on Thursday, March 6th. The shares were sold at an average price of $444.42, for a total value of $6,979,616.10. Following the completion of the transaction, the insider now owns 116,671 shares of the company's stock, valued at $51,850,925.82. The trade was a 11.86 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Also, CRO Richard S. Mahoney sold 20,838 shares of the firm's stock in a transaction that occurred on Wednesday, January 15th. The stock was sold at an average price of $506.01, for a total transaction of $10,544,236.38. Following the sale, the executive now owns 1,460 shares in the company, valued at approximately $738,774.60. This trade represents a 93.45 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 47,909 shares of company stock valued at $22,794,835 over the last three months. 0.62% of the stock is currently owned by insiders.
Synopsys Trading Up 0.6 %
Shares of SNPS stock traded up $2.61 during trading hours on Wednesday, hitting $438.55. The company's stock had a trading volume of 1,109,689 shares, compared to its average volume of 1,052,531. The business has a fifty day moving average of $481.79 and a 200-day moving average of $504.91. Synopsys, Inc. has a twelve month low of $415.29 and a twelve month high of $624.80. The stock has a market cap of $67.81 billion, a price-to-earnings ratio of 30.20, a P/E/G ratio of 3.23 and a beta of 1.16.
About Synopsys
(
Free Report)
Synopsys, Inc provides electronic design automation software products used to design and test integrated circuits. It operates in three segments: Design Automation, Design IP, and Software Integrity. The company offers Digital and Custom IC Design solution that provides digital design implementation solutions; Verification solution that offers virtual prototyping, static and formal verification, simulation, emulation, field programmable gate array (FPGA)-based prototyping, and debug solutions; and FPGA design products that are programmed to perform specific functions.
Read More
Before you consider Synopsys, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Synopsys wasn't on the list.
While Synopsys currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
